21 – 30 of 166
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
HAX-1 overexpression in multiple myeloma is associated with poor survival
(
- Contribution to journal › Letter
-
Mark
Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance : a population-based study
(
- Contribution to journal › Article
-
Mark
Outcome of an enhanced diagnostic pipeline for patients suspected of inherited thrombocytopenia
(
- Contribution to journal › Letter
-
Mark
Fetal and neonatal alloimmune thrombocytopenia : recommendations for evidence-based practice, an international approach
(
- Contribution to journal › Article
-
Mark
Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia
(
- Contribution to journal › Article
-
Mark
Comorbidities and sex differences in causes of death among mantle cell lymphoma patients – A nationwide population-based cohort study
2019) In British Journal of Haematology(
- Contribution to journal › Article
- 2018
-
Mark
Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Intravenous immunoglobulin treatment of spleen cells from patients with immune thrombocytopenia significantly increases the percentage of myeloid-derived suppressor cells
(
- Contribution to journal › Letter
-
Mark
Direct role of FLT3 in regulation of early lymphoid progenitors
(
- Contribution to journal › Article
-
Mark
Clinical-grade validation of whole genome sequencing reveals robust detection of low-frequency variants and copy number alterations in CLL
(
- Contribution to journal › Article